68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8297-8308
DOI: 10.1007/s00259-026-08097-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 14.08.2026. Verfasst von Ziyi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Heterocyclic Compounds, Immunotherapy, Lung Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.
- Key Laboratory of Nuclear Physics and Ion-Beam Application, MOE, Fudan University, Shanghai, China.
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. wangjialei@shca.org.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Z., Hu, Z., Xu, X., Liu, Q., Wu, Z., Wang, H., Zhang, J., Li, J., Wang, J., & Song, S. (2026). 68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8297-8308. https://doi.org/10.1007/s00259-026-08097-6
Vancouver
Yang Z, Hu Z, Xu X, Liu Q, Wu Z, Wang H, et al. 68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8297-8308. doi:10.1007/s00259-026-08097-6
BibTeX
@article{Yang2026,
author = {Yang, Ziyi and Hu, Zhihuang and Xu, Xiaoping and Liu, Qiufang and Wu, Zhenhua and Wang, Huijie and Zhang, Jianping and Li, Jindian and Wang, Jialei and Song, Shaoli},
title = {68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {8297--8308},
doi = {10.1007/s00259-026-08097-6}
}
EUVIMED